article thumbnail

TRAINING ARTICLE

Fierce Pharma

THIS IS WHERE THE TEXT OF THE ARTICLE WILL BE. | The introduction that will be displayed in the newsletter.

Training 215
article thumbnail

Cell therapy bigwigs endorse CAR-T in Nature Medicine article amid FDA safety probe

Fierce Pharma

A group of cell therapy experts, including CAR-T pioneers Drs. Bruce Levine and Carl June, wrote in support of continued use of CAR-T therapy.

Safety 331
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Article retractions muddy MDMA waters after FDA denial

pharmaphorum

Journal retracts three articles on MDMA-assisted psychotherapy, shortly after FDA blocks approval of @Lykos_PBC's therapy for PTSD

FDA 108
article thumbnail

Leading a New Era of Patient-Inspired Neuroscience

Fierce Pharma

Article by Richard Pops, CEO of Alkermes | Alkermes, a pioneer in neuroscience therapeutics, is building on its foundation as it emerges as a pure neuroscience company.

Leads 263
article thumbnail

Cannes Lions, Ad Forum Spotlight The Chrysalis Initiative & EVERSANA Intouch in New Webinar, Article

Eversana Intouch

Recently, Ad Forum published an article highlighting five campaigns it found to be “ Raising the Bar for Health Equity in Advertising.” And, you can read the Ad Forum article here ! One was our ongoing work with The Chrysalis Initiative, a nonprofit working to eliminate racial disparities in breast cancer treatment.

Pharma 105
article thumbnail

Ed Schoonveld Discusses Drug Pricing in the US and Upcoming Articles

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value & Access Advisor, Schoonveld Advisory, offers his thoughts on lower drug prices in the US and provides a sneak peak into future PC features.

Pharma 105
article thumbnail

10 of our most read articles of 2024

PharmaVoice

The high drama of an election year, industry layoffs, patent cliff strategies and other key trends that shaped pharma in 2024.

Pharma 59